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Abstract
Background: Malignant gastrointestinal neuroectodermal tumor (GNET) is an extremely rare entity that was first
described by Zambrano et al. in 2003 as “Clear cell sarcoma-like tumor of the gastrointestinal tract”. It shares some
of the histological features of clear cell sarcoma (CCS) but lacks the immunohistochemical reactivity for melanocytic
markers. We report a case of GNET that was initially misdiagnosed as gastrointestinal stromal tumor (GIST).
Recognizing this entity is important to avoid misdiagnosis.
Case presentation: A case of an 18-year-old male presented with a small intestinal tumor. Histologically it was
characterized by polygonal cells arranged in pseudoalveolar pattern and situated in the muscularis propria.
Scattered osteoclast-like multinucleated giant cells were also noted. The neoplastic cells were positive for S-100
protein and negative for HMB-45, Melan A, smooth muscle actin, desmin and CD117. EWSR1 gene rearrangement
was detected by fluorescence in situ hybridization (FISH) analysis. The patient returned with recurrence after
36 months’ management by surgical resection and died one year later.
Conclusions: GNET can be mistaken histologically for other non-epithelial gastrointestinal tumors. Awareness of its
existence and diagnostic criteria by the pathologist is necessary to avoid misdiagnosis, particularly as GIST, CCS or
malignant peripheral nerve sheath tumor (MPNST).
Keywords: Malignant gastrointestinal neuroectodermal tumor, Clear cell sarcoma-like tumor of gastrointestinal tract,
EWSR1
Background
Clear cell sarcoma-like tumor of the gastrointestinal
tract (CCSLTGT) or as recently designated, malignant
gastrointestinal neuroectodermal tumor (GNET) is an
extremely rare and controversial entity [1]. It was first
described in 2003 by Zambrano et al. who reported 6
cases as malignant mesenchymal neoplasm of gastro-
intestinal tract that is characterized by the presence of
osteoclast-like multinucleated giant cells, histologically,
and expresses S100 protein and is negative for CD117
and melanocytic markers, immunohistochemically. The
authors concluded that this entity shares some but not
all the features of clear cell sarcoma (CCS) [2]. Up to
our knowledge, only 44 cases that may represent GNET
were described in the English literature, 29 of which re-
ported as GNET or CCSLTGT [1–9] and 15 as CCS in
GI but lacked melanocytic differentiation [10–19]. The
clinical, morphologic, immunohistochemical and mo-
lecular/cytogenetic features of previously reported
GNET cases are presented in (Table 1). GNET can be
histologically misdiagnosed as gastrointestinal stromal
tumor (GIST), CCS or malignant peripheral nerve
sheath tumor (MPNST) by a pathologist unaware of its
existence.
Case presentation
An 18-year-old college student was referred from the
University Clinic for having low hemoglobin (Hg 4.7 g/dl).
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He was completely well till one month back when he pre-
sented with easy fatigability, postural dizziness, palpitation
and dyspnea. He gave history of 30 kg weight loss over the
past 6 months.
On physical examination, he looked pale, not jaun-
diced or cyanosed. His vital signs were all within normal
limits, except for an elevated heart rate (98/min). Car-
diovascular, respiratory and abdominal examinations
were unremarkable. Primary investigations in our hos-
pital revealed low hemoglobin level (5.1 g/dl), low iron
(<10 ug/dl), and a positive occult blood test. A
provisional diagnosis of microcytic hypochromic anemia
for further workup was made.
Bone marrow aspirate and trephine biopsy revealed
normocellular marrow, depicting normal trilineage
hematopoiesis. Upper GI endoscopy showed erosive an-
tral gastritis with patchy ulcerative inflammation. Ab-
dominal ultrasound showed a slightly enlarged liver with
a rounded echogenic lesion in the anterior wall of the
right lobe suggestive of hemangioma. The spleen was
slightly enlarged and normal in echogenicity with no
focal lesions.
Computed Tomography (CT) scan of the abdomen
and pelvis showed a fairly large well defined soft tissue
mass located in the anterior upper pelvis and engulfing
jejunal loops causing bowel wall thickening. The patient
underwent an exploratory laparotomy and excision of
the jejunal mass. Macroscopic examination revealed an
11 × 8 × 2 cm annular mass located within the jejunal
wall ulcerating through the mucosa and extending to the
serosal surface.
Microscopic examination revealed a tumor situated in
the muscularis propria and extending to the mucosa and
the serosa. The neoplastic cells were arranged in pre-
dominantly pseudoalveolar pattern (Fig. 1a,b). They were
polygonal in shape with variable amount of eosinophilic
to clear cytoplasm (Fig. 1c). The nuclei were oval with
vesicular chromatin and inconspicuous nucleoli. Scat-
tered osteoclast-like multinucleated giant cells were also
identified (Fig. 1b,c). Frequent mitotic figures and necro-
sis were noted. All lymph nodes were not involved by
tumor. Immunohistochemically, the neoplastic cells were
strongly and diffusely positive for S-100 protein (Fig. 1d).
They were also positive for vimentin. Melanocytic
markers (HMB45 and Melan A), neuroendocrine
markers (chromogranin A, synaptophysin and CD56),
smooth muscle actin, desmin, CD34, CD117, cytokeratin
and LCA were all negative in the neoplastic cells.
Fluorescein in situ hybridization (FISH) analysis for
EWSR1 break apart probe on paraffin-embedded tumor
showed evidence of a 22q12 rearrangement in 197 out
of 205 (96%) of interphase nuclei scored. The native
state of EWSR1 break apart probe will be seen as two
adjacent or fused (overlapping) red/green (yellow)
signals. However, EWSR1 gene rearrangement presented
as one red and one green separated signal (Fig. 1e).
The patient did not receive chemotherapy or radio-
therapy. During the clinical follow up, the patient
remained disease free for 3 years until he presented with
local recurrence. The treatment plan was surgical resec-
tion but the patient sought medical advice in a different
institution where he died of the disease a year later.
Discussion and Conclusions
GNET tends to occur mainly in young to middle-aged
adults. The patients present with abdominal pain, weight
loss, intestinal obstruction or an abdominal mass. Some
patients have metastatic disease at the time of diagnosis.
Most of the cases have been described in the small intes-
tine in addition to the stomach and the colon [1, 3, 5].
The reported cases followed an aggressive clinical behav-
ior with local recurrence and metastatic disease to
lymph nodes or hematogenous spread early or at the
time of diagnosis [2, 3, 6]. The etiology is unknown.
Two case reports documented a GNET that developed
after several years’ history of different other primary tu-
mors (Hepatoblastoma and neuroblastoma) that were
treated with chemotherapy and radiotherapy suggesting
that radiotherapy may play a role in development of
these tumor [8, 13]. A case of GNET was reported as a
second malignant neoplasm after history of childhood
Ewing sarcoma suggesting that they might be related [6].
GNET is centered in the wall of GI tract with exten-
sion to the mucosa and/or serosa. The tumor cells grow
in solid sheets with pseudopapillary, alveolar and nest
formation. The neoplastic cells are predominantly epi-
thelioid with oval or round nuclei with variable amount
of eosinophilic or clear cytoplasm but a case featuring
an oncocytic cytoplasm has been reported. Fascicles of
spindle cells have been also described. The nuclei display
irregular nuclear contour. The nucleoli are inconspicu-
ous but occasionally prominent and basophilic. Mitotic
activity is variable and ranging from 0 to 20 mitoses per
10 HPF. Necrosis and surface ulceration can be seen.
Osteoclast-like multinucleated giant cells is a frequent
and consistent finding in most of the tumors. Rosette-
like structures and myxoid stroma have been described.
Metastatic tumors resemble the primary tumor in mor-
phologic features including the presence of osteoclast-
like multinucleated giant cells [1, 2, 5, 7, 9]. Our case
occurred in the small intestine and followed an aggres-
sive course of disease with local recurrence and unfortu-
nate death of the patient 4 years after initial
presentation. The neoplastic cells showed similar hist-
ology to what has been described in literature including
the presence of osteoclast-like multinucleated giant cells.
Immunohistochemically, the neoplastic cells are char-
acterized by strong and diffuse staining for S100 protein.
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They also stain with SOX10. Variable reactivity is de-
scribed with CD56, synaptophysin and neuron-specific
enolase. All cases reported were uniformly negative for
HMB-45, Melan-A, tyrosinase and MiTF. They also did
not express GIST markers (CD117, DOG-1 and CD34).
Desmin and SMA were also negative. Epithelial markers
were negative except in one case that expressed CAM
5.2, but only focally and weakly [1, 2]. FLI-1 reactivity
was reported to be strongly positive in one patient. This
patient was diagnosed and treated of Ewing sarcoma
with complete remission 24 years prior to the appear-
ance of GNET. This finding in addition to EWSR1 gene
rearrangement raised the issue if Ewing sarcoma is re-
lated to GNET [6]. Our case showed strong and diffuse
S100 protein reactivity and was negative for CD117,
HMB-45 and melan-A. We were not aware of GNET at
that time and GIST diagnosis was made after exclusion
of other mesenchymal and epithelial tumors at that
location.
Of the few cases examined ultrastructurally, no mela-
nocytic, myoid or any other specific differentiation was
revealed. Instead, the neoplastic cells showed slender or
bulbous interdigitating cell processes in addition to
dense-core secretory granules [1, 2].
Antonescu and his team studied 3 cases of CCS of
gastrointestinal tract and claimed to be the first to de-
scribe a recurrent translocation of EWS (22q12) and
CREB1 (2q32.3) resulting in EWS-CREB1 fusion. They
concluded that these cases may represent a gastrointes-
tinal neuroectodermal tumor that express neuroectoder-
mal markers and lacks melanocytic differentiation.
However, the existence of rare cases of CCS of the
gastrointestinal tract with EWS-ATF1 gene fusion that
also lack melanocytic differentiation argue in favor of
common histiogenesis between the two tumors [10]. In
one study, translocation involving the gene EWSR1 was
detected in 86% (Twelve cases) of the cases described as
GNET. In the same study, the partner gene found to be
Fig. 1 a The tumor (right) is extending to the mucosa (Hematoxylin-eosin, original magnification ×40). b Tumor cells are arranged in pseudoalveolar
pattern. An osteoclast-like giant cell is also present. (Hematoxylin-eosin, original magnification × 200). c The cells are polygonal in shape with variable
amount of eosinophilic to clear cytoplasm. Characteristic osteoclast-like giant cells are dispersed in between. (Hematoxylin-eosin, original
magnification × 400). d Strong and diffuse S100 protein staining. (Original magnification × 200). e FISH analysis using dual-color, EWSR1
breakapart probe. The tumor cells show one fusion signal pattern, one green and two red, indicative of a rearrangement of one copy of
EWSR1 region
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ATF1 and was detected in 50% of the cases and CREB1
in 25% of the cases [1]. Two more studies have described
rare EWSR1-CREB1 fusion in non-gastrointestinal CCS
of soft tissue, however, these cases expressed melanocy-
tic markers [20, 21]. In our case, FISH study for EWSR1
gene was performed recently after recognition of this en-
tity and it was rearranged in keeping with the diagnosis
of GNET.
Some authors regard this entity as CCS in gastrointes-
tinal tract and explain the lack of melanocytic differenti-
ation as being a variant of CCS especially after detecting
EWSR1 rearrangement which is involved in CCS [16, 17].
Other authors considered that lack of osteoclast-like mul-
tinucleated giant cells argues against being a different en-
tity from CCS [12, 14]. However, the recognition of the
increasing number of these cases in the gastrointestinal
tract associated with lack of melanocytic differentiation
and worse clinical behavior compared to CCS of soft parts
supports the notion of being a different entity [22]. A lar-
ger number of cases needs to be studied for better histo-
logical and molecular classification.
The differential diagnosis of GNET includes GIST,
melanoma, CCS, MPNST and synovial sarcoma. GIST
needs to be excluded first because of the location of the
tumor and histologic features. GISTs feature spindle
and/or epithelioid cells which makes the distinction
from GNET difficult. However, GIST is not character-
ized by osteoclast-like multinucleated giant cells and it
expresses CD117, DOG-1 and CD34 immunohisto-
chemically. Clear cell sarcoma and melanoma need to be
considered because of some shared histological features
with GNET and S100 protein reactivity. The melanocytic
markers in this situation are invaluable to rule out these
diagnoses. Cytogenetic study for EWSR1 may not help
to separate GNET from CCS but electron microscopy
may have a role in revealing the melanocytic differenti-
ation which is not present in GNET. MPNST can enter
in the differential diagnosis because of similar histology
(spindle and/or epithelioid cells) and S100 protein re-
activity. However, MPNST usually doesn’t show strong
and diffuse reactivity for S100 protein seen in GNET and
it lacks the genetic translocation involving EWSR1 gene
[11]. Monophasic synovial sarcoma can arise in the GI
tract and the distinction from GNET can be difficult
based on morphology alone. Synovial sarcoma is charac-
terized by epithelial markers expression but S100 protein
can be expressed. In difficult cases, the detection of SYT
gene rearrangement t(X;18) can help in the distinction.
An unusual finding of oncocytic cytoplasm has been re-
cently described in GNET which raises the possibility of
malignant granular cell tumor since both tumors express
S100 protein and SOX10 immunoreactivity. Awareness
of this finding in GNET may prompt the pathologist to
avoid misdiagnosing it as malignant granular cell tumor
and investigate EWSR1 gene status to confirm the diag-
nosis of GNET [9].
In conclusion, GNET is an extremely rare malignant
tumor of the GI tract that can be mistaken for other
non-epithelial GI tumors. Awareness of its existence and
diagnostic criteria by the pathologist is necessary to
avoid misdiagnosis, particularly as GIST, CCS or
MPNST.
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